A new eye drop therapy offers a non-invasive alternative for treating dry age-related macular degeneration. Massively ...

Since July 2024, faricimab has also been approved in Europe for the treatment of visual impairment due to macular oedema ...

Korean scientists have developed a revolutionary eye drop treatment for dry age-related macular degeneration (AMD), ...

The research team led by Dr. Moon-Hyeong Seo from the Natural Product Drug Development Center at the Korea Institute of ...

Age-related macular degeneration (AMD) is the leading cause of vision loss in individuals over 65, characterized by abnormal ...

Age related macular degeneration (AMD) is the leading cause of vision loss in individuals over 65, characterized by abnormal ...

Shares of Outlook Therapeutics jumped after the company said it continues to progress the development of its treatment for wet age-related macular degeneration, which causes blurred or reduced central ...

Many people consider the symptoms of aging and blurred vision as a simple presbyopia. However, this may be an early symptom ...

Class 1 new drugs approved for clinical trials, from Sanofi, Impa Pharmaceuticals and other companies \| CDE Weekly Positive ...

INR:3598. football court measurement in meters Roche's Phase 3 clinical results of long-acting bispecific antibody are positive for the treat ...

The Korea Institute of Science and Technology (KIST) announced on the 18th that it held a signing ceremony for technology ...